Izabella Kaminska

Izabella Kaminska, Alphaville editor at the Financial Times, dives into the captivating world of DIY gene editing and biohacking. She discusses how tools like CRISPR are empowering amateur biohackers to conduct their own genetic experiments. The conversation highlights both the innovative potential and serious risks of unregulated gene manipulation, drawing parallels to the dangers of nuclear technology. With ethical concerns and safety issues on the table, this dialogue underscores the urgent need for oversight in an era of unprecedented scientific accessibility.